Theranostics
9
MENTIONS
4
EPISODES
4
PODCASTS
Search complete. 9 mentions across 4 episodes found for "Theranostics".
Sep 9, 2026
Jonathan D. GrinsteinHOST
And as head of diagnostics, you know, global head of diagnostics at Roche, I'd be very curious to know, and this is probably a discussion for another day of like what your clinical lab of tomorrow looks like.
Jonathan D. GrinsteinHOST
I very much go to talks and hear people mention maybe it's something more like Theranostic, or you have all these different bits of information amongst different biomolecules from each individual.
Jonathan D. GrinsteinHOST
And it sounds like to me, if I was to venture a guess, given that you mentioned working with NVIDIA and being able to process things quickly, That there probably is something working in the background where all of these things kind of come together in some sort of future.
Jonathan D. GrinsteinHOST
Broch to me is looking like a very, like definitely moving the needle here on precision medicine and by really investing in the diagnostic front, which is, as you said, like there is no precision medicine without diagnostics, basically.
Declan MurphyHOST
So probably while this podcast drops, we'll be just getting ready.
Declan MurphyHOST
And there are a few other European Urology family associate editors down here next week for this Prostate Meeting, PSMA, Imaging and Theranostics.
Declan MurphyHOST
So we will see who else pops up in the studio, Renu, to join the editor-in-chief.
Nikita BhattHOST
we'll see i'm sure it'll be popular super
Lance BurrellMODERATOR
Hello, and welcome to our Alpha Therapy on the Frontlines podcast.
Lance BurrellMODERATOR
My name is Lance Burrell with the SNMMI, and I am happy to be joined today by Mike Pintek, President, Nuclear and Precision Health Solutions at Cardinal Health, and Dr. Ramji Rajendran, Radiation Oncologist with EuroPartners LLC and Medical Director of Theranostics and Radiation Oncologist with the Specialty Alliance.
Lance BurrellMODERATOR
Welcome to you both.
Lance BurrellMODERATOR
Today, we will discuss emerging research involving Actinium-225, operational considerations affecting access for clinical investigation, and broader developments in theranostics.
Mike PintekGUEST
There's significant investment going into radiopharmaceutical pipelines today, and healthcare providers and pharmaceutical companies alike choose us as their partner of choice because of our differentiated service levels, along with the fact that we uniquely offer complete end-to-end services that cover everything from drug development through commercialization.
Ramji RajendranGUEST
One note at the
Mike PintekGUEST
core of our differentiated leadership capabilities is our Center for Theranostics in Indianapolis, where we work with our pharmaceutical manufacturing partners to accelerate drug development and bring novel radiopharmaceuticals to market faster with less risk.
Mike PintekGUEST
The center encompasses state-of-the-art secure facilities that includes everything from lab space to manufacturing space that can be custom built for various kinds of radiopharmaceutical manufacturing and also central pharmacy operations for dose preparation and delivery to patients in the U.S. through our nationwide nuclear pharmacy network.
Adnan MunkarahGUEST
So building residential areas, retail areas that are close to our medical campus, as well as research building is extremely important.
Adnan MunkarahGUEST
And with BAMF recently, we created the partnership to bring Theranostic, which is a high-level precision medicine, a future of care in certain areas of cancer, to bring it together to build a facility together on the LifeSense campus with the Gilbert Foundation in Rock.
Adnan MunkarahGUEST
You
Richard HelppieHOST
know, this sounds amazing for diagnostic and treatment of diseases, but And I would imagine an ability to attract researchers to come reside in Southeast Michigan and practice.